Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Trial watch: Novel antimicrobial fights TB resistance.

Crunkhorn S.

Nat Rev Drug Discov. 2012 Aug;11(8):590. doi: 10.1038/nrd3809. No abstract available.

PMID:
22814418
2.

An update on the chemistry and medicinal chemistry of novel antimycobacterial compounds.

Branco FS, Pinto AC, Boechat N.

Curr Top Med Chem. 2013;13(22):2808-49. Review.

PMID:
24111907
3.

Advances in the treatment of tuberculosis.

Zhang Y.

Clin Pharmacol Ther. 2007 Nov;82(5):595-600. Review.

PMID:
17898708
4.

Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.

Keller PM, Hömke R, Ritter C, Valsesia G, Bloemberg GV, Böttger EC.

Antimicrob Agents Chemother. 2015 Jul;59(7):4352-5. doi: 10.1128/AAC.00614-15.

5.

Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.

Kwon YS, Jeong BH, Koh WJ.

Expert Opin Pharmacother. 2015 Feb;16(2):253-61. doi: 10.1517/14656566.2015.973853. Review.

PMID:
25327169
6.

Delamanid: first global approval.

Ryan NJ, Lo JH.

Drugs. 2014 Jun;74(9):1041-5. doi: 10.1007/s40265-014-0241-5. Review.

PMID:
24923253
7.

Microbiology. TB--a new target, a new drug.

Cole ST, Alzari PM.

Science. 2005 Jan 14;307(5707):214-5. No abstract available.

PMID:
15653490
8.

Tuberculosis: clinical trials and new drug regimens.

Kwon YS, Jeong BH, Koh WJ.

Curr Opin Pulm Med. 2014 May;20(3):280-6. doi: 10.1097/MCP.0000000000000045. Review.

PMID:
24614239
9.

Infectious disease. Approval of novel TB drug celebrated--with restraint.

Cohen J.

Science. 2013 Jan 11;339(6116):130. doi: 10.1126/science.339.6116.130. No abstract available.

PMID:
23307714
10.

Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain.

Johnson R, Warren RM, van der Spuy GD, Gey van Pittius NC, Theron D, Streicher EM, Bosman M, Coetzee GJ, van Helden PD, Victor TC.

Int J Tuberc Lung Dis. 2010 Jan;14(1):119-21.

PMID:
20003705
11.

Resistance to anti-tuberculosis medications in the Horn of Africa.

Ollé-Goig JE, Codina-Grau G, Martín-Casabona N.

Int J Tuberc Lung Dis. 2011 Mar;15(3):414-6.

PMID:
21333114
12.

[Multidrug-resistant tuberculosis].

Mori T.

Ryoikibetsu Shokogun Shirizu. 1999;(23 Pt 1):192-4. Review. Japanese. No abstract available.

PMID:
10088371
13.

Bedaquiline and delamanid in tuberculosis.

Esposito S, Bianchini S, Blasi F.

Expert Opin Pharmacother. 2015;16(15):2319-30. doi: 10.1517/14656566.2015.1080240. Review.

PMID:
26293803
14.

Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.

Rattan A, Kalia A, Ahmad N.

Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209. Review.

15.

Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea.

Simpson G, Coulter C, Weston J, Knight T, Carter R, Vincent S, Robertus L, Konstantinos A.

Int J Tuberc Lung Dis. 2011 Apr;15(4):551-2. doi: 10.5588/ijtld.10.0347.

PMID:
21396218
16.

The "source" of drug-resistant TB outbreaks.

van Helden PD, Victor T, Warren RM.

Science. 2006 Oct 20;314(5798):419-20. No abstract available.

PMID:
17053131
17.

Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.

Hoffmann H, Kohl TA, Hofmann-Thiel S, Merker M, Beckert P, Jaton K, Nedialkova L, Sahalchyk E, Rothe T, Keller PM, Niemann S.

Am J Respir Crit Care Med. 2016 Feb 1;193(3):337-40. doi: 10.1164/rccm.201502-0372LE. No abstract available.

PMID:
26829425
18.

New generation methods for drug susceptibility testing for tuberculosis.

Katoch VM.

Indian J Tuberc. 2008 Apr;55(2):61-3. No abstract available.

PMID:
18516820
19.

Infectious disease. Drug-resistant TB on the rise.

Stokstad E.

Science. 2000 Mar 31;287(5462):2391. No abstract available.

PMID:
10766610
20.

Drug-resistant tuberculosis: what do we do now?

Telenti A, Iseman M.

Drugs. 2000 Feb;59(2):171-9. Review.

PMID:
10730543
Items per page

Supplemental Content

Support Center